ANTI-AGING MEDICINE IS A TREND IN MODERN RUSSIAN MEDICINE
Issue:
6
Year:
2016
The paper sets forth the main current views of a new area, such as anti-aging medicine, the implementation of effective individual programs for preventing the development and progression of chronic diseases and age-related conditions. It presents the used innovative diagnostic methods, as well as prevention and treatment programs based on peptidergic regulation.
Keywords:
personalized medicine
anti-aging medicine
molecular genetic testing
biological age estimation
peptide bioregulators
decreased morbidity
References:
- Anisimov V.N. Molekuljarnye i fiziologicheskie mehanizmy starenija. V 2 t. 2-e izd., pererab. i dop. / SPb: Nauka, 2008.
- Anisimov V.N. Melatonin i ego mesto v sovremennoj meditsine // RMZh. – 2006; 14 (4): 269–73.
- Anisimov V.N., Kvetnoj I.M., Komarov F.I. i dr. Melatonin v fizio logii i patologii zheludochno-kishechnogo trakta / M.: Sovetskij sport, 2000; 184 s.
- Il'nitskij A.N., Proschaev K.I. Nemnogo istorii i sovremennaja kontsep tsija geriatrii // Meditsinskaja sestra. – 2014; 5: 4–6.
- Il'nitskij A., Trofimova S., Belov D. i dr. Preventivnaja geriatrija kak novoe napravlenie v klinicheskoj praktike // Vrach. – 2015; 6: 29–31.
- Kvetnaja T.V., Knjaz'kin I.V., Kvetnoj I.M. Melatonin – nejroimmuno endokrinnyj marker vozrastnoj patologii / SPb: DEAN, 2005; s. 106–7.
- Morozov V.G., Havinson V.H. Novyj klass biologicheskih reguljatorov mnogokletochnyh sistem – tsitomediny // Uspehi sovremennoj biologii. – 1983; 96, Vyp. 3 (6): 339–52.
- Morozov V.G., Havinson V.H. Rol' kletochnyh mediatorov (tsitomedi nov) v reguljatsii geneticheskoj aktivnosti // Izvestija AN SSSR. Ser. «Biologija» – 1984; 4: 581–7.
- Ponomareva I.P. Sovremennaja strategija palliativnoj pomoschi v geriatrii // Meditsinskaja sestra. – 2015; 4: 4–7
- Prognoz dolgosrochnogo sotsial'no-ekonomicheskogo razvitija Rossijskoj Federatsii na period do 2030 goda / M.: Minekonomrazvitija RF, 2013.
- Trofimov A., Trofimova S. 15-letnij opyt primenenija molekuljarno geneticheskogo issledovanija v klinicheskoj praktike // Vrach. – 2015; 6: 66–8.
- Havinson V.H., Molekuljarnye osnovy peptidergicheskoj regljatsii starenija / SPb: Nauka, 2011; 174 s.
- Havinson V.H., Solov'ev A.Ju., Tarnovska S.I. i dr. Mehanizm biologi cheskoj aktivnosti korotkih peptidov: proniknovenie v kletku i epigenetiche-skaja reguljatsija ekspressii genov // Uspehi sovremennoj biologii. – 2013; 133 (2): 197–203.
- Damjanovic A., Yang Y., Glaser R. et al. Accelerated telomere erosion is . associated with a declining immune function of caregivers of Alzheimer's disease patients // J. Immunol. – 2007; 179 (6): 4249–54.
- Dardente H., Dardente H., Cermakian N. Molecular circadian rhythms in central and peripheral clocks in mammals // Chronobiol. Intern. – 2007; 24 (2): 195–213.
- Fitzpatrick W., Lowry N. PLEDs: clinical correlates // Can. J. Neurol. Sci. – 2007; 34 (4): 443–50.
- Hoffmann J., Spyridopoulos I. Telomere length in cardiovascular disease: new challenges in measuring this marker of cardiovascular aging // Future Cardiol. – 2011; 7 (6): 789–803.
- Khavinson V., Malinin V. Gerontological Aspects of Genom Peptide Regulation / Basel (Switzerland): Karger AG, 2005; 104 p
- Kuznetsova T., Codd V., Brouilette S. et al. Association between left ventricular mass and telomere length in a population study // Am. J. Epidemiol. – 2010; 172 (4): 440–50.
- Njajou O., Cawthon R., Damcott C. et al. Telomere length is paternally inherited and is associated with parental lifespan // Proc. Natl. Acad. Sci. USA. – 2007; 104 (29): 12135–9.
- Takubo K., Izumiyama-Shimomura N., Honma N. et al. Telomere lengths are characteristic in each human individual // Exp. Gerontol. – 2002; 37: 523–31.
- Xiao F., Zheng X., Cui M. et al. Telomere dysfunction-related serological 22. markers are associated with type 2 diabetes // Diabetes Care. – 2011; 34 (10): 2273–8.